Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications
Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications have?
Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications has 197 citations in the OpenAlex counts ScholarIQ stores.
When was Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications published?
Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications has 2009 year in the ScholarIQ index.
What is the open-access status of Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications?
Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications has hybrid oa status in the ScholarIQ index.
What is the DOI of Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications?
The DOI for Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications is on the source record.
What is the PMID of Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications?
The PMID for Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications is on the source record.
What is the OpenAlex record for Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications?
The OpenAlex for Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications is on the source record.